ProLung Announces Change to its Board of Directors
In News
ProLung Announces Change to its Board of Directors Salt Lake City, UT, November 26, 2019 –...
Read More
ProLung, Inc. presents highest combined sensitivity and specificity values for a truly non-invasive lung cancer solution pursuing FDA clearance at ISRD & ATS joint medical conference
In News
ProLung, Inc. presents highest combined sensitivity and specificity values for a truly non-invasive lung cancer...
Read MoreProLung, Inc. Announces Large Clinical Validation Trial Results of 84% sensitivity and 74% specificity
In News
ProLung, Inc. Announces Large Clinical Validation Trial Results of 84% sensitivity and 73% specificity Salt Lake...
Read More
ProLung Promotes Jared Bauer from interim CEO to CEO
In News
ProLung Promotes Jared Bauer from interim CEO to CEO Salt Lake City, UT, October 2, 2019...
Read MoreProLung Announces the Appointment of Leavitt Partners and Mr. Rich McKeown to its Board of Directors
In News
ProLung Announces the Appointment of Leavitt Partners and Mr. Rich McKeown to its Board of...
Read More
ProLung interim CEO, Jared Bauer, is a “Top Creative Leader Innovating in Business 2019” by Insights Success Magazine – ProLung, Inc.
ProLung interim CEO, Jared Bauer, is a “Top Creative Leader Innovating in Business 2019” by...
Read More
ProLung Announces Changes to its Board of Directors and Leadership Team to Enhance its Medtech Expertise – ProLung, Inc.
In News
ProLung Announces Changes to its Board of Directors and Leadership Team to Enhance its Medtech...
Read More
ProLung Announces New Office Location as Anchor Tenant at ‘The Labs at Northgate’ – ProLung, Inc.
In News
ProLung Announces New Office Location as Anchor Tenant at 'The Labs at Northgate' – ProLung,...
Read More
ProLung named Med Tech Company of the Year 2019 by Global Health & Pharma – ProLung, Inc.
ProLung named Med Tech Company of the Year 2019 by Global Health & Pharma –...
Read More
ProLung Announces Preliminary Results from its PL-208 Clinical Trial and Next-Steps – ProLung, Inc.
In News
ProLung Announces Preliminary Results from its PL-208 Clinical Trial and Next-Steps – ProLung, Inc. Salt Lake...
Read More